Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introduction to the medication regimen review--part 3.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2011
Same author

Introduction to medication regimen review-part 2.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2010
Same author

Introduction to the medication regimen review--Part 1.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2010
Same author

Comment on K. L. Lapane et al. "Does incorporating medications in the surveyors' interpretive guidelines reduce the use of potentially inappropriate medications in nursing homes?".

Journal of the American Geriatrics Society·2008
Same author

The application of evidence-based principles of care in older persons (issue 5): Alzheimer's disease.

Journal of the American Medical Directors Association·2007
Same author

Imidazo[1,2-b]pyridazines, novel nucleus with potent and broad spectrum activity against human picornaviruses: design, synthesis, and biological evaluation.

Journal of medicinal chemistry·2003

Related Experiment Video

Updated: May 16, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Medication therapy management: a challenge for pharmacists.

Joseph Gruber1

  • 1Dublin, Ohio American Society of Consultant Pharmacists.

The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
|November 22, 2012
PubMed
Summary

Medication Therapy Management (MTM) services provided by pharmacists have evolved significantly since the Medicare Modernization Act of 2003. This evolution highlights economic and clinical benefits, despite implementation barriers.

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Related Experiment Videos

Last Updated: May 16, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Area of Science:

  • Health Services Research
  • Pharmaceutical Sciences
  • Health Policy

Background:

  • Pharmacists have historically provided personalized patient services, but recognition and fair payment for cognitive services have lagged.
  • The Medicare Modernization Act of 2003 served as a catalyst for the formalization and expansion of pharmacist-provided services.

Purpose of the Study:

  • To track the evolution of Medication Therapy Management (MTM) services offered by pharmacists.
  • To examine MTM programs within the Medicare Part D outpatient prescription drug benefit.
  • To evaluate pharmacist and patient perceptions and barriers related to MTM implementation.

Main Methods:

  • Review of core elements and services within MTM.
  • Examination of MTM programs under Medicare Part D.
  • Analysis of studies demonstrating economic and clinical benefits of MTM.
  • Evaluation of barriers to MTM implementation at the pharmacy level.

Main Results:

  • MTM services have evolved, with Medicare Part D outlining specific programs and benefits.
  • Pharmacist and patient perceptions of MTM value are documented.
  • Barriers to MTM implementation exist at the pharmacy and pharmacist level.
  • Key studies confirm the economic and clinical advantages of MTM.

Conclusions:

  • MTM services represent a significant advancement in pharmacist-led patient care.
  • Understanding perceptions and barriers is crucial for broader MTM adoption.
  • Evidence supports the economic and clinical value of MTM, suggesting potential for expansion beyond current Medicare thresholds.